Randy F. Sweis

Randy Sweis practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Randy Sweis' NPI, 1093034498, was assigned on May 25, 2010. Randy Sweis graduated from University of Chicago, Pritzker School of Medicine in 2010. Randy Sweis holds Illinois license 036132765.

Randy Sweis' primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Randy Sweis' primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Randy Sweis is also affiliated with University of Chicago Medical Center. The medical group on file is OhioHealth Physician Group. Dmand AI also links Randy Sweis to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Randy Sweis practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Randy Sweis' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Randy Sweis is licensed in Illinois.

CMS data shows 295 Medicare services from Randy Sweis across 4 procedure codes in 2024, for 101 Medicare patients. Medicare paid $20,960 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 101 Medicare patients who saw Randy Sweis in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have cancer, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Randy Sweis' median patient age at 71, with 28% women.

In 2024, Randy Sweis wrote 322 Medicare Part D claims for 62 patients. 72% of them were for generic drugs. CMS names the drug for 231 of them, across 6 drugs with 11 or more claims each, at $1,391,390 in total drug cost. In 2023, CMS named 201 claims across 4 drugs.

Randy Sweis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Randy Sweis as offering telehealth.

Dmand AI links 57 papers to Randy Sweis, published from 2011 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Urinary Bladder Neoplasms, Immunotherapy and Antibodies, Monoclonal, Humanized. Randy Sweis has published most often in Clin Cancer Res. Randy Sweis' most frequent co-authors are Jason J. Luke, MD, Thomas F. Gajewski and Alexander T. Pearson.

Dmand AI links Randy Sweis to 5 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Ureteral Neoplasms, Lymphoma and Squamous Cell Carcinoma of Head and Neck. National Cancer Institute (NCI) sponsors the most, 2. Open Payments lists research payments to Randy Sweis that name 1 trial.

CMS Open Payments shows 345 general payments to Randy Sweis from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Exelixis Inc. paid the most, $134,011. It also lists 5 research payments totaling $888 in 2025, naming 1 clinical trial.

Randy Sweis graduated from University of Chicago, Pritzker School of Medicine in 2010.